Motley Fool Asset Management's Bill Mann sees a durable AI build-out alongside a potentially painful correction, making debt burdens and portfolio concentration central questions for investors.
Author and advocate Laura Carroll on why patients with Alzheimer's, ALS, and other neurodegenerative diseases are shut out of medical aid in dying laws--and what families can do to prepare.